impact factor, citescore
logo
 

Letters to the Editor

 

Resolution of ocular and mediastinal sarcoidosis after Janus kinase inhibitor therapy for concomitant rheumatoid arthritis


1, 2, 3, 4, 5, 6

 

  1. Department of Ophthalmology, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, Lyon, France 5-UMR-CNRS 5510 Matéis, Villeurbanne, France.
  2. Department of Ophthalmology, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, Lyon, France 5-UMR-CNRS 5510 Matéis, Villeurbanne, France.
  3. Department of Rheumatology, Grenoble Alpes University Hospital, Grenoble, France.
  4. Department of Internal Medicine, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, France.
  5. Department of Internal Medicine, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, France.
  6. Department of Internal Medicine, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, and Pôle IMER, Lyon, France; HESPER EA 7425, Lyon, France. pascal.seve@chu-lyon.fr

CER13464
2021 Vol.39, N°1
PI 0225, PF 0226
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 32662408 [PubMed]

Received: 17/04/2020
Accepted : 25/05/2020
In Press: 30/06/2020
Published: 05/02/2021

Rheumatology Article